Biotherapeutics development

Next generation biotherapeutics based on complex consortia from intestinal microbiota.

Our revolutionary product GutAlive® together with our in-house technology bring us to the next level on biotherapeutics development. We can now isolate and store intestinal microbiota in viable conditions, to study and understand the microbes that have a key role in human health. This pipeline enables us to develop next generation biotherapeutics based on complex consortia from intestinal microbiota that can be used to improve human health.